Amgen Inc.
Pharmaceutical composition comprising bispecific antibody constructs

Last updated:

Abstract:

The present invention provides novel and stable pharmaceutical compositions comprising bispecific single chain antibody constructs, cyclodextrins and a buffer.

Status:
Grant
Type:

Utility

Filling date:

25 Jan 2017

Issue date:

23 Aug 2022